Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Herpes Simplex Encephalitis: an Update.

Gnann JW Jr, Whitley RJ.

Curr Infect Dis Rep. 2017 Mar;19(3):13. doi: 10.1007/s11908-017-0568-7. Review.

PMID:
28251511
2.

Genital Herpes.

Gnann JW Jr, Whitley RJ.

N Engl J Med. 2016 Nov 10;375(19):1906. doi: 10.1056/NEJMc1611877. No abstract available.

PMID:
27959656
3.

CLINICAL PRACTICE. Genital Herpes.

Gnann JW Jr, Whitley RJ.

N Engl J Med. 2016 Aug 18;375(7):666-74. doi: 10.1056/NEJMcp1603178. Review. No abstract available.

PMID:
27532832
4.

Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia.

MacVane SH, Hurst JM, Boger MS, Gnann JW Jr.

Infect Dis (Lond). 2016 Oct;48(10):732-7. doi: 10.1080/23744235.2016.1185533. Epub 2016 May 19.

PMID:
27196015
5.

Gnann JW et al (Clin Infect Dis 2015; 61:683-91). Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.

Gnann JW, Sk├Âldenberg B, Hart J.

Clin Infect Dis. 2016 Feb 15;62(4):530. doi: 10.1093/cid/civ1011. Epub 2015 Dec 24. No abstract available.

6.

Disseminated Herpes Simplex Virus with Fulminant Hepatitis.

Rimawi BH, Meserve J, Rimawi RH, Min Z, Gnann JW Jr.

Case Reports Hepatol. 2015;2015:463825. doi: 10.1155/2015/463825. Epub 2015 Jul 28.

7.

Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.

Gnann JW Jr, Sk├Âldenberg B, Hart J, Aurelius E, Schliamser S, Studahl M, Eriksson BM, Hanley D, Aoki F, Jackson AC, Griffiths P, Miedzinski L, Hanfelt-Goade D, Hinthorn D, Ahlm C, Aksamit A, Cruz-Flores S, Dale I, Cloud G, Jester P, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..

Clin Infect Dis. 2015 Sep 1;61(5):683-91. doi: 10.1093/cid/civ369. Epub 2015 May 8. Erratum in: Clin Infect Dis. 2016 Feb 15;62(4):530. Dosage error in article text.

8.

Long-term persistence of zoster vaccine efficacy.

Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, Betts R, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman CA, Marques A, Toney J, Boardman K, Su SC, Li X, Chan IS, Parrino J, Annunziato P, Oxman MN; Shingles Prevention Study Group..

Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20.

9.

West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes.

Hart J Jr, Tillman G, Kraut MA, Chiang HS, Strain JF, Li Y, Agrawal AG, Jester P, Gnann JW Jr, Whitley RJ; NIAID Collaborative Antiviral Study Group West Nile Virus 210 Protocol Team..

BMC Infect Dis. 2014 May 9;14:248. doi: 10.1186/1471-2334-14-248.

10.

Reversible posterior leukoencephalopathy syndrome.

Min Z, Gnann JW Jr.

Intern Emerg Med. 2014 Apr;9(3):341-2. doi: 10.1007/s11739-013-1011-1. Epub 2013 Oct 17. No abstract available.

PMID:
24132656
11.

Kaposi's varicelliform eruption.

Min Z, Gnann JW Jr.

Intern Emerg Med. 2014 Feb;9(1):101-2. doi: 10.1007/s11739-013-1001-3. Epub 2013 Sep 14. No abstract available.

PMID:
24036906
12.

Mosquito bites and eastern equine encephalitis.

Min Z, Gnann JW Jr.

QJM. 2014 May;107(5):397-8. doi: 10.1093/qjmed/hct168. Epub 2013 Aug 22. No abstract available.

PMID:
23970186
13.

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

J Infect Dis. 2013 Nov 1;208(9):1386-90. doi: 10.1093/infdis/jit342. Epub 2013 Aug 1.

14.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW; Shingles Prevention Study Group..

J Infect Dis. 2013 Aug 15;208(4):559-63. doi: 10.1093/infdis/jit182. Epub 2013 Apr 30.

15.

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, Morrison VA, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman C, Marques A, Toney J, Keller PM, Li X, Chan IS, Annunziato P; Shingles Prevention Study Group..

Clin Infect Dis. 2012 Nov 15;55(10):1320-8. doi: 10.1093/cid/cis638. Epub 2012 Jul 24.

16.

Varicella-zoster virus: Prevention through vaccination.

Gnann JW Jr.

Clin Obstet Gynecol. 2012 Jun;55(2):560-70. doi: 10.1097/GRF.0b013e3182510b67. Review.

PMID:
22510639
17.

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.

Brehm JH, Scott Y, Koontz DL, Perry S, Hammer S, Katzenstein D, Mellors JW, Sluis-Cremer N; AIDS Clinical Trials Group Study 175 Protocol Team..

PLoS One. 2012;7(2):e31558. doi: 10.1371/journal.pone.0031558. Epub 2012 Feb 21.

18.

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.

19.

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.

Schmader KE, Johnson GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, Chan IS, Yeh SS, Levin MJ, Harbecke RM, Oxman MN; Shingles Prevention Study Group..

J Am Geriatr Soc. 2010 Sep;58(9):1634-41. doi: 10.1111/j.1532-5415.2010.03021.x.

20.

Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.

Artman T, Schilling D, Gnann J, Molls M, Multhoff G, Bayer C.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):574-82. doi: 10.1016/j.ijrobp.2009.08.035.

PMID:
20117293

Supplemental Content

Loading ...
Support Center